Search research articles
Contact Us
Filters
Showing results (411-420 of 520) with videos related to
Page
of 52
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 20, 2013
Underestimated role of 18F-FDG PET for HCC evaluation and promise of 18F-FDG PET/MR imaging in this setting
Marnix G E H Lam, Thomas C Kwee, Sandip Basu, et al.
Journal of Cancer Research and Therapeutics
|
May 19, 2010
18 F-FDG avid lesion due to coexistent fibrous dysplasia in a child of embryonal rhabdomyosarcoma: source of false positive FDG-PET
Sandip Basu, N S Baghel, Ajay Puri, et al.
Frontiers in Bioscience (Elite Edition)
|
December 29, 2011
Functional oncoimaging techniques with potential clinical applications
Thomas C Kwee, Sandip Basu, Babak Saboury, et al.
Journal of Nuclear Medicine Technology
|
June 9, 2026
Pictorial Essay of [<sup>18</sup>F]FDG PET/CT in the Evaluation of Suspected Infection of Cardiac Devices and Infective Endocarditis: Patient Preparation, Pathophysiologic Findings, and Interpretation
Austin Saju, Sunita Sonavane, Keyur Rajendra Rathod, et al.
Nuclear Medicine Communications
|
April 10, 2026
Pilot feasibility study investigating 68Ga-NODAGA-RGD PET-computed tomography molecular angiogenesis imaging in patients with peripheral arterial diseases: can it be of potential clinical value?
Vishwajeet Jadhav, Priyanka Verma, Ashok Chandak, et al.
Nuclear Medicine Communications
|
May 7, 2008
Determination of whole-body metabolic burden as a quantitative measure of disease activity in lymphoma: a novel approach with fluorodeoxyglucose-PET
Arnold Berkowitz, Sandip Basu, Shyam Srinivas, et al.
Clinical Nuclear Medicine
|
August 18, 2012
Prognostic significance of FDG PET/CT on the follow-up of patients of differentiated thyroid carcinoma with negative 131I whole-body scan and elevated thyroglobulin levels: correlation with clinical and histopathologic characteristics and long-term follow-up data
Gulin Ucmak Vural, Burcu Esen Akkas, Nur Ercakmak, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 13, 2011
Defining the role of modern imaging techniques in assessing lymph nodes for metastasis in cancer: evolving contribution of PET in this setting
Thomas C Kwee, Sandip Basu, Drew A Torigian, et al.
Endocrine
|
March 25, 2025
Evaluating the prognostic significance of the pre-treatment neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios in <sup>177</sup>Lu-DOTATATE PRRT treated patients with advanced metastatic neuroendocrine tumors
Mahesh K Padwal, Amir K Nazar, Rahul V Parghane, et al.
Clinical Nuclear Medicine
|
November 17, 2012
Potential role of FDG PET/CT imaging for assessing venous thromboembolic disorders
Søren Hess, Poul Henning Madsen, Sandip Basu, et al.
Page
of 52
Search research articles
Search
Showing results (411-420 of 520) with videos related to
Sort By:
Page
of 52
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 20, 2013
Underestimated role of 18F-FDG PET for HCC evaluation and promise of 18F-FDG PET/MR imaging in this setting
Marnix G E H Lam, Thomas C Kwee, Sandip Basu, et al.
Journal of Cancer Research and Therapeutics
|
May 19, 2010
18 F-FDG avid lesion due to coexistent fibrous dysplasia in a child of embryonal rhabdomyosarcoma: source of false positive FDG-PET
Sandip Basu, N S Baghel, Ajay Puri, et al.
Frontiers in Bioscience (Elite Edition)
|
December 29, 2011
Functional oncoimaging techniques with potential clinical applications
Thomas C Kwee, Sandip Basu, Babak Saboury, et al.
Journal of Nuclear Medicine Technology
|
June 9, 2026
Pictorial Essay of [<sup>18</sup>F]FDG PET/CT in the Evaluation of Suspected Infection of Cardiac Devices and Infective Endocarditis: Patient Preparation, Pathophysiologic Findings, and Interpretation
Austin Saju, Sunita Sonavane, Keyur Rajendra Rathod, et al.
Nuclear Medicine Communications
|
April 10, 2026
Pilot feasibility study investigating 68Ga-NODAGA-RGD PET-computed tomography molecular angiogenesis imaging in patients with peripheral arterial diseases: can it be of potential clinical value?
Vishwajeet Jadhav, Priyanka Verma, Ashok Chandak, et al.
Nuclear Medicine Communications
|
May 7, 2008
Determination of whole-body metabolic burden as a quantitative measure of disease activity in lymphoma: a novel approach with fluorodeoxyglucose-PET
Arnold Berkowitz, Sandip Basu, Shyam Srinivas, et al.
Clinical Nuclear Medicine
|
August 18, 2012
Prognostic significance of FDG PET/CT on the follow-up of patients of differentiated thyroid carcinoma with negative 131I whole-body scan and elevated thyroglobulin levels: correlation with clinical and histopathologic characteristics and long-term follow-up data
Gulin Ucmak Vural, Burcu Esen Akkas, Nur Ercakmak, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 13, 2011
Defining the role of modern imaging techniques in assessing lymph nodes for metastasis in cancer: evolving contribution of PET in this setting
Thomas C Kwee, Sandip Basu, Drew A Torigian, et al.
Endocrine
|
March 25, 2025
Evaluating the prognostic significance of the pre-treatment neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios in <sup>177</sup>Lu-DOTATATE PRRT treated patients with advanced metastatic neuroendocrine tumors
Mahesh K Padwal, Amir K Nazar, Rahul V Parghane, et al.
Clinical Nuclear Medicine
|
November 17, 2012
Potential role of FDG PET/CT imaging for assessing venous thromboembolic disorders
Søren Hess, Poul Henning Madsen, Sandip Basu, et al.
Page
of 52